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Abstract
Purpose It is well reported that dry eye symptoms
can increase after many refractive surgery procedures.
This study aims to provide a clinical understanding of
the correlation of fluorescein tear film breakup time
(FTBUT) with quality of vision (QoV) and dry eye
symptoms following small incision lenticule extrac-
tion surgery (SMILE).
Methods Patients electing to have SMILE surgery
were subdivided into 2 groups: Group 1 included short
preoperative FTBUTs of 3 to 6 seconds (s); Group 2
included long FTBUTs ofC 8 s. Uncorrected distance
visual acuity, corrected distance visual acuity, mani-
fest refraction, FTBUT, QoV and Ocular Surface
Disease Index (OSDI) questionnaires were recorded 1
and 6 months postoperatively.
Results Thirty-nine subjects were included in each
group. There was no significant difference in visual
outcomes between the 2 groups at both the 1- and
6-month postoperative assessments. FTBUT remained
significantly lower in group 1. Oxford staining was
initially higher for group 1 at 1 month (P = 0.007), but
there was no significant difference at 6 months
(P = 0.180). There was no significant difference in
QoV or OSDI scores between the 2 groups at both
postoperative visits.
Conclusions Low preoperative FTBUT (3–6 s) does
not appear to negatively affect postoperative visual
outcomes or results in a greater likelihood of dry eye
symptoms and poor ocular surface compared to eyes
with a longer preoperative FTBUT. These results
suggest that a low preoperative FTBUT does not
necessarily increase the likelihood of poor visual
acuity, dry eyes symptoms, or poor ocular surface
outcomes following SMILE surgery.
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Dry eye disease (DED) is a well-known complication
of laser-assisted in situ keratomileusis (LASIK) post-
treatment of refractive errors. While the majority of all
LASIK patients may suffer from some degree of dry
eye symptoms within 1 month of surgery as part of the
healing response [1], these symptoms can remain in up
to 36% of patients 6-month postoperatively [2] leading
to decreased patient satisfaction and persistent dis-
comfort [3]. Mechanical and postoperative inflamma-
tory factors have been identified in the multifactorial
driven pathophysiology [4]. Creation of the LASIK
flap within the anterior corneal stroma as well as
stromal ablation severs most of the sensory corneal
nerves and thus disrupts the neural feedback loop to
ocular surface and lacrimal gland and the blink
mechanism, which is important in maintaining a
healthy ocular surface [4–6]. Consequently, corneal
sub-basal nerve density is significantly decreased after
LASIK and it may take up to 5 years for recovery [7].
The introduction of small incision lenticule extrac-
tion (SMILE) has enabled a corneal laser refractive
treatment which is less invasive resulting in reduced
impact upon both the corneal biomechanics and tear
film. The small corneal surface incision and the
formation of a refractive lenticule by femtosecond
laser deeper within the posterior corneal stroma result
in preservation of more anterior corneal nerve fibers
and improve the postoperative health of the ocular
surface [8]. A history of preoperative dry eye has been
identified as one of the main risk factors of experi-
encing dry eye symptoms after LASIK [9]. However,
with the less invasive impact of SMILE on the cornea
and, therefore, on DED, more patients may be safely
treated despite their preexisting condition. Especially
as more patients with contact lens intolerance or DED
are seeking independence from glasses, SMILE may
offer a more suitable treatment. Furthermore, various
types of laser corneal refractive surgery including
SMILE surgery have been associated with increased
ocular aberration measurements [10]. Altered tear
films demonstrating short FTBUTs have similarly
been associated with ocular aberrations [11]. These
findings raise the question, as to whether short
FTBUTs may influence the perceived quality of vision
(QoV) of SMILE patients after surgery. A FTBUT of
10 seconds (s) or greater is still deemed as normal
[12]; however, it is well accepted now that a high
percentage of laser refractive patients are treated
safely with a FTBUT well under 10 s. Therefore, this
retrospective study sought to assess the correlation of
preoperative FTBUT with postoperative QoV and dry
eye symptoms following SMILE surgery.
Methods
This retrospective non-randomized study included 100
consecutive patients (200 eyes) undergoing bilateral
SMILE surgery for their refractive error between
January 2017 and January 2018. Patients were divided
into two groups based upon their preoperative
FTBUT. According to a previous study, patients
experienced mild dry eye syndrome with a FTBUT
of 7 s and below [13]. In this cohort of 200 eyes, the
mean FTBUT was 7.5 ± 2.4 s. The mean FTBUT of
each patient’s two eyes was recorded and patients
were then subdivided based upon this mean score.
Since the study was aiming to investigate the differ-
ence between two distinct groups, any patient with a
mean FTBUT of 7 s was excluded (n = 22). Patients
with a mean FTBUT of 3 to 6 s were categorized as
low FTBUT and labelled Group 1 (n = 39). The
lowest FTBUTwas 3 s, as patients with significant dry
eye signs were considered unsuitable for laser vision
correction. Patients with a mean FTBUT of C 8 s
were categorized into the long FTBUT and labelled
Group 2 (n = 39). Furthermore, the monocular
FTBUT was compared between each patients’ two
eyes to determine if a patient had a FTBUT in group 1
and their fellow eye was in group 2. This was not
found to be the case with any patient in this study.
Exclusion criteria were as follows:
• Refractive stability less than 2 years.
• Uncontrolled dry eye disease.
• History of glaucoma.
• Past retinal detachment.
• Ocular inflammation.




Full ophthalmic assessment was performed on all
patients preoperatively. The examination included a
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medical history, uncorrected (UDVA) and corrected
(CDVA) distance visual acuities, autorefraction
(OPD-Scan II ARK-10000, Nidek Co., Gamagori,
Japan), subjective and manifest refraction (RT-5100
Auto Phoropter Head, Nidek Co., Gamagori, Japan),
keratometry, topography, slit-lamp examination,
Goldmann tonometry, dilated fundus examination
and retinal optical coherence tomography (Cirrus
4000 OCT; Carl Zeiss Meditec, Jena, Germany).
Visual acuity measures were evaluated with logMAR
distance charts at 6 m.
FTBUT was measured preoperatively and postop-
eratively. The patient was asked to blink a couple of
times to allow uniform distribution. Once achieved,
the FTBUT was measured, with a stopwatch, as the
interval between the last blink and the first appearance
of a dry spot on the corneal surface using a broad beam
of cobalt blue light with aWratten filter to aid viewing.
The test was repeated three times consecutively at
each visit and an average was taken [12–14]. FTBUT
was measured following completion of visual acuity
testing and scanning.
Patients were examined at 1 month and at 6 months
postoperatively. Full ophthalmic examination was
performed postoperatively using the same techniques
as preoperatively.
A specifically developed QoV questionnaire was
completed postoperatively [15]. The questionnaire
assessed the severity of symptoms that patients
experienced. Patients responded on a Likert scale
either not at all (0), a little (1), quite (2) or very (3).
Additionally, patients were asked regarding their own
subjective view of their total QoV on a linear scale of 0
to 10 (0 the worst, 10 the best) to gain a better
understanding of each patient’s postoperative satis-
faction. Standard categorical analysis techniques were
utilized to look for statistical differences between each
item between groups.
To assess dry eye symptoms, the ocular surface
disease index (OSDI) was used, which was introduced
in 1997 by the Outcomes Research Group (Allergan
Inc., Irvine, CA, USA) [16]. It consists of 12 questions
graded from a scale of 0 to 4, where 0 indicates none of
the time; 1, some of the time; 2, half of the time; 3,
most of the time; and 4, all of the time. The total OSDI
score was then calculated by the following formula
with a score of 100 as the highest, with higher scores
representing more disability: OSDI = [(sum of scores
for all questions answered) 9 100]/[(total number of
questions answered) 9 4] [16, 17]. The OSDI scores
can be used to define ocular surface disability due to
dry eye disease and are grouped as normal/no disabil-
ity: 0–12, mild: 13–22, moderate: 23–32, or severe:
33–100 [18].
Each patient gave their informed consent for the
surgical procedure and an audit of the findings for this
study, including for publication. The Tenets of the
Declaration of Helsinki were adhered to throughout
this work.
Surgical technique
All SMILE surgeries were performed by the same
experienced surgeon (JEM) using topical anesthesia
(0.4% oxybuprocaine hydrochloride). Bilateral
SMILE was performed using a femtosecond laser
(Visumax, Carl Zeiss Meditec, Jena, Germany) with a
135 lm cap, 6.5-mm optical zone, and a 2-o’clock
small tunnel incision. After careful separation of the
lenticule, it is extracted through the corneal incision
with a blunt spatula. After surgery, the patient was
assessed on a slit lamp and one drop of fluorescein dye
eye drops applied in both eyes. Postoperative therapy
includes the combination of tobramycin 0.3% and
dexamethasone 0.1% as well as ofloxacin 0.3% eye
drops twice daily for one week. Patients were encour-
aged to use lubricating drops as required postopera-
tively and were encouraged to use them often in
addition to the routine suggested by the clinician. Use
of lubricating drops was therefore not recorded as
maximal optimization of the ocular surface was
enforced in all patients and subsequently adapted to
the clinical need of the patient.
Statistical analysis
Statistical analysis was performed using SPSS for
Windows (Statistical Package for the Social Sciences,
Version 22, Chicago, Illinois, USA) and Excel (Mi-
crosoft; Redmond, Washington, USA). The Indepen-
dent Samples t test was used for parametric analysis.
When assessing nonparametric data, a Mann–Whitney
U test was utilized. Following the methods outlined by
Goodall et al. [19], calculations indicated that for this
study to have 80% statistical power, the sample size
required was more than 36 patients per group. A
standard deviation of 0.90 for the QoV score was used
and a difference of 0.6 in QoV was considered to be
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clinically significant. For all statistical analysis, the
level of significance was P\ 0.05.
Results
Demographics
Group 1 consisted of 39 patients (FTBUT 3 to 6 s) and
Group 2 consisted of 39 patients (FTBUT C 8 s). The
mean age in group 1 was 32 ± 5.7 years compared to
29 ± 4.4 years in group 2. There was a higher
percentage of females in group 1, with 79% compared
to 38% in group 2. A statistically significant difference
in FTBUT between the groups (P\ 0.001, indepen-
dent t test) is displayed. There was no statistical
difference in preoperative visual and refractive param-
eters. The preoperative QoV score was 8.5 ± 1.3 for
the night and 9.0 ± 1.2 for day in Group 1, and Group
2 showed a night rating of 8.40 ± 1.8 and a day rating
of 8.8 ± 1.8. There was no statistically significant
difference between the groups for the day (P = 0.63,
independent t test) or nighttime QoV scores (P = 0.71,
independent t test). The OSDI scores are within the
normal range in both groups, and there is no significant
difference in OSDI between groups 1 and 2 (P = 0.52,
independent t test). Particularly for group 1, the OSDI
score is 1.2 ± 1.9, which suggests there is no symp-
tomatic disability due to ocular surface dryness,
despite a short FTBUT.
Quality of vision (QoV) and photopic phenomena
Table 1 compares and outlines the individual symptom
responses and the overall QoV scores 1 and 6 months
after SMILE surgery. No significant differences in the
overall day and night QoV scores at both 1 and
6 months were found. Glare was the only symptom
that was found to be statistically different between the
2 groups at 1 month (P = 0.011, Wilcoxon Signed
Rank); however, there was no statistically significant
difference at 6 months (P = 0.059, Wilcoxon Signed
Rank).
Visual and refractive outcomes
A statistical difference mean spherical equivalent
(MSE) between the 2 groups at 1 month (P = 0.003,
independent t test) and 6 months (P = 0.001,
independent t test) was found. There was no statisti-
cally significant difference in CDVA at 1 month
(P = 0.460, independent t test) and 6 months
(P = 0.795, independent t test). A statistically signif-
icant difference in refractive sphere between the 2
groups at 1 month (P = 0.001, independent t test) and
at 6 months (P = 0.002, independent t test) was found.
OSDI and dry eye clinical findings
Group 1 showed a significantly higher Oxford staining
(P = 0.007, Mann–Whitney U) at 1 month, but no
significant difference was evident between the 2
groups at 6 months. With a FTBUT of 5.15 ± 1.7 s
at 1 month and 6.79 ± 2.9 at 6 month, Group 1
retained a lower FTBUT compared to Group 2 with a
FTBUT of 5.63 ± 1.97 at 1 month (P = 0.001, inde-
pendent t test) and of 7.31 ± 2.1 (P\ 0.001, inde-
pendent t test) at 6 month over the whole observation
period. There was no significant difference in postop-
erative OSDI scores between the 2 groups. Figure 1
displays the percentage of patients within the graded
scales of the OSDI questionnaire and how this altered
over the two postoperative periods. All 39 patients in
each group reported ‘normal’ OSDI scores preopera-
tively and 37 and 39 patients in the two respective
groups at 6 months. Two patients reported ‘mild’
OSDI scores at 6 months in group 1.
Discussion
It is widely understood that DED is a well-known
complication of LASIK and is a cause of reduced
satisfaction following refractive surgery [3]. This
study aimed to assess if the SMILE procedure results
in a reduced impact on the ocular surface, indicating
that it is a safe procedure even in the presence of mild
dry eye. The tear film impacts the clarity of an image
and has significant visual importance; therefore, in this
study, the FTBUT was considered as the defining
preoperative parameter. Furthermore, it is relatively
quick and simple to assess within the normal clinical
routine and is a widely utilized and is an instantly
recognizable clinical measurement. However, there is
reported variability with this measurement [17]. An
earlier study, by the authors, reported that dry eye
symptoms significantly correlate to a FTBUT ofB 7 s
[9]. Therefore, in choosing to exclude the mean
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FTBUT of 7 s in this study, it served as a qualitative
marker to clearly distinguish between the preoperative
FTBUT groups. This decision is further supported by
Lee et al., who reported higher reproducibility for
FTBUT B 5 s in dry eyes than for normal eyes thus
indicating the reliability of a short FTBUT [20]. This
gave two distinct groups, one group had a low
preoperative FTBUT (3–6 s) and the other a high
preoperative FTBUT (C 8 s). The groups were based
upon the mean of the two eyes with the main outcome
measurement of this study being subjective outcomes
which is a binocular assessment. Assessment of the
monocular FTBUT of each patient showed that no
patients had one eye that would be defined by this
study as having a low FTBUT and the fellow eye a
long FTBUT. Furthermore, it was found that if the
lowest FTBUT of each patient’s two eyes was used it
would not have changed the patients in each group in
this study and therefore the mean FTBUTwas utilized.
This study assessed the correlation of preoperative
FTBUT with both the objective visual and refractive
outcomes and the subjective QoV and OSDI in
patients who underwent SMILE surgery.
FTBUT was the defining parameter preoperatively
and it was found that the mean FTBUT for group 1
remained significantly lower than group 2 at both the
1-month and 6-month postoperative assessments.
Studies have shown that a lower FTBUT impacts the
optical image on the retina [21, 22]. However, in this
current study, there was no significant difference
between objective visual and refractive outcomes.
Both groups showed excellent UDVA at both postop-
erative assessments, with no significant difference.
There was a significant difference in MSE; however, it
appears that this difference is not clinically significant.
The UDVA achieved in this current study is excellent
and appears to be superior to that found in other studies
[23]. Similar to the objective visual outcomes, there is
no significant difference between the two groups in
subjective reports of blurred vision or fluctuation of
vision. A low preoperatively FTBUT appears to cause
more glare at 1 month; however, this reduced at
6 months. There appears to be a high level of
postoperative satisfaction in both groups with
9.03 ± 0.95 and 9.20 ± 0.86 at 1 month and
9.33 ± 0.91 and 9.62 ± 0.60 at 6 months in the two
respective groups. It appears that the lower FTBUT
group does not significantly report worse day or
nighttime QoV scores postoperatively (Table 1).
It has been found previously that corneal staining
following SMILE is significantly less when compared
to LASIK [24]. Comparison of the corneal staining in
this current study showed no significant difference
preoperatively between the two groups. Patients are
not recommended to proceed with surgery if signif-
icant corneal staining is present and are advised to
Table 1 Between-group
comparison of QOV at 1
and 6 months
postoperatively
1 month Group 1 Group 2 P value
QOV night 8.97 ± 1.24 9.26 ± 0.78 0.947
QOV day 9.03 ± 0.95 9.20 ± 0.86 0.571
How much does glare bother you? 0.64 ± 0.81 0.00 ± 0.00 0.011
How much do the haloes bother you? 0.50 ± 0.50 0.00 ± 0.00 0.157
How much do the starbursts bother you? 0.43 ± 0.50 0.10 ± 0.30 0.655
How much does blurred vision bother you? 0.38 ± 0.70 0.01 ± 0.26 0.564
How much do fluctuations bother you? 0.33 ± 0.67 0.19 ± 0.39 1.00
6 month Group 1 Group 2 P value
QOV night 9.06 ± 1.25 9.26 ± 0.95 0.658
QOV day 9.33 ± 0.91 9.62 ± 0.60 0.681
How much does glare bother you? 0.19 ± 0.58 0.00 ± 0.00 0.059
How much do the haloes bother you? 0.00 ± 0.00 0.00 ± 0.00 0.317
How much do the starbursts bother you? 0.00 ± 0.00 0.00 ± 0 0.564
How much does blurred vision bother you? 0.15 ± 0.44 0.00 ± 0.37 0.589
How much do fluctuations bother you? 0.06 ± 0.24 0.09 ± 0.28 1.00
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optimize their tear film and will be assessed in the
clinic again prior to proceeding with any surgery.
Postoperatively at the 1 month assessment, group 1
showed significantly more corneal staining; however,
the Oxford score remained low at 0.32 ± 0.59. There
was no significant difference between the two groups
at 6 months. Similarly, there was no significant
difference between groups in conjunctival folds at
either postoperative assessment. The implication of
SMILE has been reported to have a less severe impact
upon the corneal innervation and thus the anterior
surface [25], which appears to concur with this current
study. It appears that having a lower preoperative
FTBUT prior to SMILE surgery does not significantly
increase the presence of clinical signs of dry eye
postoperatively. This is also reflected in postoperative
subjective outcomes through the OSDI questionnaire.
This study highlighted a low level of OSDI, and
similarly to the QoV outcomes, there was no signif-
icant difference between the two groups. Figure 1
displays the number of patients within the defined
severity grades within the OSDI questionnaire. In
group 1, all patients reported ‘‘normal’’ symptoms
preoperatively, however 6 months postoperatively 2
patients reported to have ‘‘mild’’ dry eye symptoms.
This further suggests that having a lower FTBUT does
(a)
(b)
0-12   = Normal 12-22 = Mild 23-32 =Moderate >33 = Severe
Preoperative 100% 0% 0% 0%
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Fig. 1 Percentage of
patients reporting dry eye
symptoms based on ocular
surface disease index
(OSDI) preoperatively and
6 months after surgery.
a Group 1, b Group 2
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not significantly impact a patient’s subjective dry eye
symptoms.
This study appears to suggest that the presence of a
low FTBUT preoperatively is not a contraindication to
proceeding with SMILE surgery. Patients with a lower
FTBUT preoperatively (3 to 6 s) do not report
significantly lower QOV or worse dry eye symptoms.
This is also reflected in the objective visual outcomes
and clinical signs of dry eye. This study appears to
highlight that SMILE surgery is safe to perform in
patients with a low FTBUT. This is supported by a
previous which suggests that SMILE surgery can
result in a decrease in dry eye symptoms postopera-
tively [26].
The limitations of this study include the heteroge-
nous groups reported. There was a significant differ-
ence in age between the two groups, with the mean age
and standard deviation 32 ± 5.7 in group 1, and
29 ± 4.4 in group 2. The gender between the two
groups may also have had an impact upon the
outcomes; therefore, these factors will be assessed in
future studies. However, the impact of postoperative
lubricating efforts is not reported by this study and
may confound the results. Usually patients, who are
more aware of their symptoms tend to use their drops
more regularly. This should however decrease the
difference between both groups in this study and
diminish the effect found. Therefore, it could be
concluded that this study depicts significant clinical
results despite its limitations, which may help for
preoperative selection of patients for refractive
surgery.
With the recent publication of the ‘‘Refractive
Errors & Refractive Surgery Preferred Practice Pat-
tern’’ by the American Academy of Ophthalmology,
uncontrolled dry eye syndrome is mentioned as
contraindication for corneal refractive surgery [27].
Toda et al. found that the efficacy and safety of LASIK
were not affected by preexisting dry eye status, but
resulted in more severe postoperative dry eye [28].
Similarly, this paper highlights that the preoperative
tear film does not significantly impact the postoper-
ative QoV following SMILE surgery. Therefore, while
being eligible for laser refractive surgery, well-
controlled DED with low preoperative FTBUT will
benefit from additional management and assessment
before and after surgery.
In conclusion, this study has demonstrated that
SMILE surgery would appear subjectively and
objectively safe to carryout despite low preoperative
FTBUTs. However, as this study has concentrated on
the impact of the dry eye indicator FTBUT only,
further studies are necessary to investigate the impact
of different dry eye measures to identify eligible
patients for refractive surgery. Especially, with the
recent development of SMILE and of additional
therapeutic options for DED, refractive surgery may
become available for more patients.
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